Cargando…

Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation

Detalles Bibliográficos
Autores principales:	Israni, Anil V., Mandal, Anirban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982484/ https://www.ncbi.nlm.nih.gov/pubmed/29899791 http://dx.doi.org/10.4103/JPN.JPN_13_17

Ejemplares similares

Genetics of Lafora progressive myoclonic epilepsy: current perspectives
por: Kecmanović, Miljana, et al.
Publicado: (2016)

Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)()
por: Schorlemmer, Kathrin, et al.
Publicado: (2013)

Spinocerebellar Ataxia type 17 presenting with progressive myoclonic epilepsy
por: Boongird, Apisit, et al.
Publicado: (2023)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

Clinical Evaluation of 38 Patients with Juvenile Myoclonic Epilepsy
por: NASER MOGHADASI, Abdorreza, et al.
Publicado: (2014)

Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora
por: Pellegrini, Pasquale, et al.
Publicado: (2021)

Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019)

Neuropsychological Testing in Patients in Juvenile Myoclonic Epilepsy: Are They Required in Every Patient?
por: Panda, Prateek Kumar, et al.
Publicado: (2022)

Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020)

Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism
por: Couarch, Philippe, et al.
Publicado: (2011)

Progressive myoclonic epilepsy due to rare mitochondrial ND6 mutation, m.14487T>C
por: Khoo, Anthony, et al.
Publicado: (2021)

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

Radiomic Models for Diagnosing Juvenile Myoclonic Epilepsy Should Note Its Genetic Heterogeneity
por: Finsterer, Josef
Publicado: (2023)

Progressive myoclonic epilepsy with Fanconi syndrome
por: Seaby, Eleanor G, et al.
Publicado: (2016)

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023)

Screening of mutations in NOL3 in a myoclonic syndromes series
por: Macerollo, A., et al.
Publicado: (2014)

Response to the paper titled “Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy”
por: Graves, Tracey D
Publicado: (2018)

Response to “Radiomic Models for Diagnosing Juvenile Myoclonic Epilepsy Should Note Its Genetic Heterogeneity”
por: Kim, Kyung Min, et al.
Publicado: (2023)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

Late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A spectrum of progressive myoclonic epilepsy — Case report
por: Sharma, Chandra Mohan, et al.
Publicado: (2016)

Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Auvin, Stéphane
Publicado: (2007)

MRI characteristics due to gene mutations in a Chinese pedigree with Lafora disease
por: Sun, Yueqian, et al.
Publicado: (2023)

A Novel Mutation in Lafora Disease and Update on Pathophysiology and Future Treatments
por: Nordli, Douglas R., et al.
Publicado: (2022)

Vagus nerve stimulation in Lafora body disease()
por: Hajnsek, Sanja, et al.
Publicado: (2013)

Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019)

Cerebral Evoked Potentials in Familial Progressive Myoclonic Epilepsy
por: Halliday, A. M.
Publicado: (1967)

A Quandary of Cuprum - Wilson’s Disease Disguising as Progressive Myoclonic Epilepsy
por: Sachan, Monika, et al.
Publicado: (2017)

Headache in juvenile myoclonic epilepsy
por: Schankin, Christoph J., et al.
Publicado: (2011)

Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
por: Makke, Yamane, et al.
Publicado: (2015)

EFHC1 mutation in Indian juvenile myoclonic epilepsy patient
por: Thounaojam, Romita, et al.
Publicado: (2017)

Myoclonic Status Epilepticus of Unknown Etiology in an Elderly Patient
por: Kim, Hyun Kyung
Publicado: (2018)

Wolff-Parkinson-White Syndrome in a Patient with Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Syndrome Mimicking Juvenile Myoclonic Epilepsy
por: Sung, Joo Hye, et al.
Publicado: (2018)

An empirical pipeline for personalized diagnosis of Lafora disease mutations
por: Brewer, M. Kathryn, et al.
Publicado: (2021)

Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy
por: Lv, Yudan, et al.
Publicado: (2017)

Acamprosate-induced myoclonic jerks: A rare side effect
por: Soni, Puneet Kumar, et al.
Publicado: (2021)

Insulinoma misdiagnosed as juvenile myoclonic epilepsy
por: Jaladyan, Varsine, et al.
Publicado: (2006)

Cognitive Impairment in Juvenile Myoclonic Epilepsy
por: Kim, Sun-Young, et al.
Publicado: (2007)

Predictors of Outcome in Juvenile Myoclonic Epilepsy
por: Chen, Yiqian, et al.
Publicado: (2020)

Trait impulsivity in Juvenile Myoclonic Epilepsy
por: Shakeshaft, Amy, et al.
Publicado: (2020)

Personality disorders and Juvenil Myoclonic Epilepsy
por: Santos Carrasco, I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tu9grijnfb5jva6s8pqqlkpkmr